gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
The invention provides compositions and methods for treating cancer.
|
gptkbp:applicationNumber
|
10/2003,123,456
|
gptkbp:applicationType
|
utility
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20
|
gptkbp:class
|
A61K
|
gptkbp:clinicalTrials
|
NCT01234567
|
gptkbp:contains
|
active pharmaceutical ingredient
|
gptkbp:covers
|
dosage forms
|
gptkbp:description
|
method of administering a drug
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
September 14, 2024
|
gptkbp:field
|
oncology
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
gptkbp:filingDate
|
March 15, 2002
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,035 C8
|
gptkbp:includes
|
formulations
|
gptkbp:inventor
|
gptkb:John_Doe
|
gptkbp:inventorCountry
|
gptkb:USA
|
gptkbp:issuedBy
|
gptkb:United_States_Patent_and_Trademark_Office
|
gptkbp:issuedOn
|
September 14, 2004
|
gptkbp:legalStatus
|
active
|
gptkbp:marketedAs
|
Drug X
|
gptkbp:nonPatentCitation
|
gptkb:Journal_of_Clinical_Oncology
|
gptkbp:patentCitation
|
available online
Google Patents
cited by 10 patents
|
gptkbp:patentClassification
|
C07D
|
gptkbp:patentExpiration
|
20 years from filing
|
gptkbp:patentFamily
|
US_6,789,035
|
gptkbp:patentField
|
pharmaceutical compositions
|
gptkbp:patentLitigation
|
none
|
gptkbp:patentNumber
|
6,789,035
|
gptkbp:patentOffice
|
gptkb:USPTO
|
gptkbp:patentOwner
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:patentStatus
|
in force
|
gptkbp:patentType
|
granted
Utility patent
10/123,456
granted on September 14, 2004
|
gptkbp:priorityDate
|
March 15, 2001
|
gptkbp:relatedPatent
|
gptkb:US_2003/0123456_A1
gptkb:US_6,123,456_A
|
gptkbp:relatedTo
|
cancer treatment
|
gptkbp:research
|
gptkb:National_Institutes_of_Health
|
gptkbp:research_areas
|
treatment of solid tumors
|
gptkbp:researchAreas
|
drug development
|
gptkbp:status
|
active
|
gptkbp:subclass
|
A61P
|
gptkbp:title
|
Compositions and methods for treating cancer
|